Hillstar Bio is a biotechnology company developing immunology therapies that selectively target and deplete pathogenic immune cells to treat autoimmune diseases.

Callio Therapeutics develops multi-payload antibody-drug conjugates for cancer therapy.

Alesta Therapeutics is a biotechnology company developing oral small molecule therapies for rare diseases.

Maze Therapeutics is a biopharmaceutical company focused on developing precision medicines for renal and metabolic diseases using human genetics.

Alentis Therapeutics is a biotech company developing antibody-drug conjugates for treating Claudin-1 positive tumors and organ fibrosis.

Alpha-9 Oncology Inc. develops targeted radiopharmaceuticals to improve cancer treatment.

Sudo Biosciences is a biopharmaceutical company developing TYK2 inhibitor candidates for the treatment of multiple sclerosis, neurodegenerative, and immune-mediated dermatologic diseases.

Lassen Therapeutics is a clinical-stage biotech company developing novel treatments for fibro-inflammatory diseases and cancer, focusing on therapies targeting the IL-11 and IL-18 pathways.